Screener
Emergent Biosolutions EBS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's free cash flow?
- Emergent Biosolutions (EBS) reported free cash flow of $54M in Q2 2026.
- How has Emergent Biosolutions's free cash flow changed year-over-year?
- Emergent Biosolutions's free cash flow decreased by 47.8% year-over-year, from $103.5M to $54M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Emergent Biosolutions's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude